Taiwan FDA registration 8612db1cbf2e548ddbc925c1adff3352

Abbott "Myurise" human T-lymphotropic virus type 1 and type 2 antibody test reagent

TW: 亞培”妙芮絲”人類嗜T淋巴球病毒第一型及第二型抗體檢驗試劑
Taiwan flagTaiwan·Risk Class 3·DIASORIN S.P.A. UK BRANCH·Registered Aug 08, 2005 – Aug 12, 2027Active
Registration details
Analysis ID
8612db1cbf2e548ddbc925c1adff3352
Customs Code
DHA00601173900
Company information
Manufacturer Country
United Kingdom
Product details
Intended Use
Enzyme immunoassay for legal testing of human T-lymphotropic virus type 1 and type 2 antibodies in human serum or plasma for screening.
Product Type (Level 1)
B Hematology, pathology, and genetics
Product Type (Level 2)
B.4020 Analysis of specific tests
Import Information
import
Dates and status
Registration Date
Aug 08, 2005
Expiry Date
Aug 12, 2027
About this record

Access comprehensive regulatory information for Abbott "Myurise" human T-lymphotropic virus type 1 and type 2 antibody test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 8612db1cbf2e548ddbc925c1adff3352 and manufactured by DIASORIN S.P.A. UK BRANCH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices